Schrödinger, Inc.
NASDAQSDGR reports Q1 2026 results today with one of the more interesting short-side setups in health care technology — a heavily shorted name where the bears have quietly been retreating. Short interest remains substantial at nearly 17% of the free float, making SDGR one of the more contested stocks in its peer group. Yet the trend has been moving against the shorts…
Snapshot as of 6 May 2026
SDGR reports Q1 2026 results today with one of the more interesting short-side setups in health care technology — a heavily shorted name where the bears have quietly been retreating. Short interest remains substantial…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SDGR — free to start on ORTEX.
Sign up for free →Open SDGR on ORTEX